Main Catalog

Found 95
Sort By
Nexus 2019
Member Free
Non-Member

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.
Social Determinants
Nexus 2019
Member Free
Non-Member

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.
Specialty Drug Spend
Nexus 2019
Member Free
Non-Member

Specialty Pharmaceuticals in Development - Nexus 2019

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus 2020 Virtual
Member
Non-Member

Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Contact Hours: 1 - Prescription drug reference pricing is an emerging pharmacy benefit management tool that aligns plan reimbursement to clinical value.
Drug Pricing
Nexus 2020 Virtual
Member
Non-Member

Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Contact Hours: 1 - Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems.
Biosimilars
Nexus 2020 Virtual
Member
Non-Member

Population Management: Zooming in on Rare Diseases with ICER Reports

Contact Hours: 1 - An estimated 10% of the population has a rare disease, according to the National Organization of Rare Disorders (NORD), which lists over 1,200 rare diseases.
ICER
Nexus 2020 Virtual
Member
Non-Member

Specialty Pharmaceuticals in Development Nexus 2020

Contact Hours: 1 - Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus 2020 Virtual
Member
Non-Member

The Evolving Role of Managed Care in the Gene Therapy Era: Focus on Hemophilia

Contact Hours: 1 - The first gene therapies for hemophilia A and B are expected to reach the market by 2022, with more projected in the coming years.
Gene Therapy
Nexus 2020 Virtual
Member
Non-Member

The State of Prescription Drug Pricing Reform: Are States Leading the Way for the US?

Contact Hours: 1 - Debates from Washington, D.C. frequently drown out changes happening in state capitals. This is true for drug pricing as well.
Drug Pricing
Nexus 2019
Member Free
Non-Member

The Managed Care Evaluation of Non-Alcoholic Steatohepatitis Treatment Options

Contact Hours: 1.5. Non-alcoholic steatohepatitis (NASH) is a liver disease resulting from metabolic dysfunction that can lead to serious and costly health conditions, such as inflammation, hepatocellular injury, progressive fibrosis, and cirrhosis.
NASH
Nexus 2019
Member Free
Non-Member

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
Nexus 2019
Member Free
Non-Member

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers, and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).
Health Care Reform
Nexus 2019
Member Free
Non-Member

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.
Value-Based Contracting
Nexus 2019
Member Free
Non-Member

Releasing Format Version 4.1: Updates, Perspectives and Application

Contact Hours: 1.5. The Academy of Managed Care Pharmacy developed the AMCP Format for Formulary Submission
Format 4.1
Nexus 2019
Member Free
Non-Member

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.
Drug Shortages
Certificate Programs
Member
Non-Member

Medical Benefits Training - Provider & Health Plan Version

AMCP’s Medical Benefit Medication Management is an 8-part series built specifically for members of Life Science companies.
Medical Benefits Training
Certificate Programs
Member
Non-Member

Medical Benefits Training - Life Sciences Version

AMCP’s Medical Benefit Medication Management is an 8-part series built specifically for members of Life Science companies.
Medical Benefits Training
Certificate Programs
Member
Non-Member

Value-Based Contracting E-Learning Program

Not accredited for CPE: An interactive self-paced e-Learning training program designed to fit into your busy schedule and deliver the basics with seven 40-minute modules.
Value-Based Contracting
Certificate Programs
Member
Non-Member

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

Not Accredited for CPE: The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
Certificate Programs
Member
Non-Member

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 - The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy